Back to the main directory
EarningsReview / Equity
- Vitrolife (Buy, TP: SEK230.00) - Disappointing start to 2025 by DnB Markets
- Bufab (Hold, TP: SEK420.00) - Time to bolt in by DnB Markets
- Nokia (Buy, TP: EUR5.10) - One-off blew momentum off course by DnB Markets
- Huhtamaki (Buy, TP: EUR42.00) - Q1 mixed elements by DnB Markets
- Alimak (Hold, TP: SEK125.00) - Order beat, earnings miss by DnB Markets
- Green Landscaping Group (Buy, TP: SEK93.00) - Tough Q1 with Swedish bright spot by DnB Markets
- ENI capex cut but maintains shareholder returns by DnB Markets
- FQ1’25 postview: Demonstrating traction in multiple areas by BNP Paribas Exane
- Stewards of capital and a good night of sleep by BNP Paribas Exane
- Itaú BBA on Vale: In-Line 1Q25 Results; Solid Cost Performance by Itau
- Itaú BBA on Orbia: Uneventful 1Q25; Corporate Action Needed by Itau
- Itaú BBA on Parque Arauco: Malls Momentum Maintained, Results In Line by Itau
- Jiangsu Hengrui Medicine (600276 CH) by HSBC
- Itaú BBA on Megacable: Strong EBITDA Margin, Tainted by a Bottom-Line Miss by Itau
- Building blocks in place by BNP Paribas Exane
- One-off credit-cost relief delivers earnings beat by BNP Paribas Exane
- SBI Cards & Payment (SBICARD IN) by HSBC
- SBI Life (SBILIFE IN) by HSBC
- Intel Corp (INTC US) by HSBC
- Essity - Cash-back continues; keep Buying by Danske Bank Equity Research
- Q125: Where do we stand on the Caution Barometer? by BNP Paribas Exane
- Handling a fluid situation by BNP Paribas Exane
- Orion - Hold: Nubeqa held up better than expected by Nordea
- FQ1’25 postview: FY outlook maintained, but discretionary weakness adds risk by BNP Paribas Exane
- Positive commentary in regard to pipeline, valuation attractive by BNP Paribas Exane
- Protector (Buy, TP: NOK380.00) - Well within targets by DnB Markets
- Kinnevik (Buy, TP: SEK100.00) - Set for a new chapter by DnB Markets
- Nordnet (Buy, TP: SEK293.00) - Firing on all cylinders by DnB Markets
- Konecranes (Buy, TP: EUR75.00) - Holding up nicely by DnB Markets
- Paradox Interactive (Buy, TP: SEK240.00) - More releases ahead by DnB Markets
- The weekly navigator by DnB Markets
- Itaú BBA on Kimberly Clark de Mexico: 4% Lower Than Expected EBITDA & EPS, Will this Mark the Bottom in Results? by Itau
- Q1’25 Postview: swiftly returning to a gloomy near term outlook by BNP Paribas Exane
- Tariffs ahoy by BNP Paribas Exane
- Itaú BBA on Axtel: EBITDA Beat thanks to Extraordinary Uncollectible Provision Benefit by Itau
- Itaú BBA on Liverpool: Topline and EBITDA Beat; But Keep an Eye on Working Capital by Itau
- Itaú BBA on Southern Copper: 1Q25 Results - Slight Beat Due to Higher Top-Line by Itau
- 恒瑞医药 (600276 CH) by HSBC
- Itaú BBA on Multiplan: A Good Start of the Year; 1Q25 Results by Itau
- St James's Place (STJ LN) by HSBC
- Margins and compounding surprise positively by BNP Paribas Exane
- Opex led beat, critical credit cost improvement lags expectations by BNP Paribas Exane
- TechnipFMC (FTI US) by HSBC
- Mips - Long-term potential, but keep the helmet on for now by Danske Bank Equity Research
- Aiming to close the discount, but is convergence good for them? by BNP Paribas Exane
- Choosing sides by BNP Paribas Exane
- AAK - Hold: Earnings growth slowing to a trickle by Nordea
- Paradox Interactive - Hold: Underlying margins remain solid by Nordea
- Good Quarter, High Bar: Thesis Little Changed Post Solid 1Q and Reaffirmed Guidance; Maintain Neutral Rating by BNP Paribas Exane
- Q1 beat with guidance confirmed: results first take and read across by BNP Paribas Exane